STOCK TITAN
  1. Home
  2. Sec-filings
  3. DRMA
  4. [EFFECT] Dermata Therapeutics, Inc. SEC Filing

[EFFECT] Dermata Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 29, 2026 5:00 P.M.
Form: S-3
CIK: 0001853816
Company Name: Dermata Therapeutics, Inc.
File Number: 333-292885

Source: View Original Filing on SEC EDGAR

Stock DRMA logo
Dermata Therapeutics Inc

NASDAQ:DRMA

DRMA Rankings

#6506 Ranked by Market Cap
N/A Ranked by Dividends

DRMA Latest News

Jan 20, 2026
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
Dec 29, 2025
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 24, 2025
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 4, 2025
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
Nov 14, 2025
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

DRMA Latest SEC Filings

Jan 29, 2026
[424B3] Dermata Therapeutics, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 27, 2026
[8-K] Dermata Therapeutics, Inc. Reports Material Event
Jan 27, 2026
[424B5] Dermata Therapeutics, Inc. Prospectus Supplement (Debt Securities)
Jan 22, 2026
[S-3] Dermata Therapeutics, Inc. Shelf Registration Statement
Jan 6, 2026
[Form 4] Dermata Therapeutics, Inc. Insider Trading Activity

DRMA Stock Data

7.97M
1.39M
17%
7.46%
1.91%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO